[The role of new dihydropyridine calcium channel blockers in the treatment of hypertension].
作者信息
Coca A
出版信息
An Med Interna. 2003 Jun;20(6):279-81.
PMID:12848596
Abstract
摘要
相似文献
1
[The role of new dihydropyridine calcium channel blockers in the treatment of hypertension].
An Med Interna. 2003 Jun;20(6):279-81.
2
[Molecular effects of new calcium antagonists: is the principle of parcimony out of place?].[新型钙拮抗剂的分子效应：简约原则是否不适用？]
Ann Cardiol Angeiol (Paris). 2008 Jun;57(3):166-73. doi: 10.1016/j.ancard.2008.02.019. Epub 2008 Jun 4.
3
4
[Evaluation of lercanidipine in the general practice setting].
An Med Interna. 2003 Jun;20(6):282-6.
5
Use of nifedipine in the treatment of hypertension.
Expert Rev Cardiovasc Ther. 2005 Jan;3(1):43-50. doi: 10.1586/14779072.3.1.43.
6
Ca2+ channel subtypes and pharmacology in the kidney.肾脏中的钙离子通道亚型与药理学
Circ Res. 2007 Feb 16;100(3):342-53. doi: 10.1161/01.RES.0000256155.31133.49.
7
The use of calcium-channel blockers in pregnancy.
New Horiz. 1996 Feb;4(1):115-22.
8
Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.克利夫地平：一种用于治疗急性高血压的超短效钙通道拮抗剂。
Ann Pharmacother. 2009 Jul;43(7):1258-65. doi: 10.1345/aph.1L610. Epub 2009 Jul 7.
9
Calcium channel blockers and nephroprotection.
Aging Clin Exp Res. 2005 Aug;17(4 Suppl):31-9.
10
Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?在抗高血压治疗期间，钙通道阻滞剂比利尿剂能更好地保护肾功能吗？
Arch Intern Med. 2005 Jun 13;165(11):1312; author reply 1312-3. doi: 10.1001/archinte.165.11.1312-a.
Zotero 插件